论文部分内容阅读
目的:探讨2μm激光汽化切除术治疗高危前列腺增生(BPH)的安全性和有效性。方法:高危前列腺增生症患者50例,采用行经尿道前列腺汽化切除术,应用德国RevoLix产激光手术系统,波长2μm,输出功率120 W,连续输出。观察平均手术时间、术中出血量、术后留置尿管时间、手术并发症,记录并计算手术前后国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)及残余尿量(PVR)等指标的差异。
Objective: To investigate the safety and efficacy of 2 μm laser vaporization in the treatment of high-risk benign prostatic hyperplasia (BPH). Methods: Fifty patients with benign prostatic hyperplasia (BPH) were treated by transurethral vaporization of the prostate. The laser was applied to the RevoLix laser operating system at a wavelength of 2μm and the output power was 120 W. The output was continuous. The mean operative time, intraoperative blood loss, postoperative indwelling catheter time and operative complications were recorded and the scores of IPSS, QOL, Qmax and residual before and after surgery were recorded and calculated Urine output (PVR) and other indicators of the difference.